ReviewACS applied materials & interfaces2025
Surface-Modified Nanozymes for Enhanced and Selective Catalysis.
Review in ACS applied materials & interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Glycine-Copper Nanozyme with Dual Oxidase Activity: for Colorimetric Detection of Epinephrine and Oxidation of Phenolic Pollutants.ACS omega · 2026Article
- Nanozyme-Driven Signal Amplification in Cancer Biosensing: Innovations Toward Precision and Point-of-Care Oncology.Micromachines · 2026Review
- Advances in artificial metabzymes for macrophage polarization in tumor metabolic immunotherapy.Materials today. Bio · 2026Article
- Nanozyme-Driven Ferroptosis-Cuproptosis Interplay in Lung Cancer.International journal of nanomedicine · 2026Review
- Biogenic synthesis of magnetic nanozymes with peroxidase-like activity for water remediation.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Surface-modified catalytic nanoparticles (nanozymes) are introduced as hybrid nanoparticles overcoming basic limitations associated with bare nanozymes that include moderate catalytic turnovers, lack of substrate selectivity and chiroselectivity, and poor or nonselective permeabilities into biomembrane. This review introduces aptamer-modified nanozymes, receptor (cyclodextrins)- or ligand (amino acids, peptides)-functionalized catalytic nanoparticles, and molecularly imprinted polymer-coated nanozymes as hybrid frameworks improving the catalytic properties and selective/chiroselective functions of the nanozymes. Binding of the reaction substrates to the aptamers, ligands, or molecular-imprinted sites, by affinity interactions, concentrates the substrates in spatial proximity to the nanozyme catalytic sites ("molarity effect"), thereby enhancing the catalytic performance of the frameworks. Specific and chiroselective binding interactions of the substrates to the surface modifiers lead to selective or chiroselective chemical transformations. Moreover, by appropriate molecular engineering of the surface modifiers on the nanozymes, catalytic functions lacking in the parent bare nanozymes are demonstrated. Potential applications of surface-modified nanozymes are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.